N-Nitroso Nortriptyline D3 | N-Nitroso Amitriptyline EP Impurity C-D3
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. N-Nitroso Nortriptyline D3can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Nitrosamines . N-Nitroso Nortriptyline D3 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Nortriptyline D3 CAS NO:NA is also known as N-Nitroso Amitriptyline EP Impurity C-D3 Chemically represented as N-(3-(10,11-Dihydro-5H-dibenzo[a,d][7]annulen-5-ylidene)propyl)-N-(methyl-d3)nitrous amide. Synchemia is the leading manufacturing and exporter of N-Nitroso Nortriptyline D3. We supply N-Nitroso Nortriptyline D3 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142386 |
| CAS No | NA |
| Mol.F. | C13H18N2O5S |
| Mol.Wt. | 314.36 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142387 |
| CAS No | 2492451-27-9 |
| Mol.F. | C6H13N5O3 |
| Mol.Wt. | 203.2 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142388 |
| CAS No | NA |
| Mol.F. | C15H20N4O3S3 |
| Mol.Wt. | 400.5 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142389 |
| CAS No | NA |
| Mol.F. | C13H19N3O4S |
| Mol.Wt. | 313.37 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142390 |
| CAS No | NA |
| Mol.F. | C12H17N3O4S |
| Mol.Wt. | 299.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142391 |
| CAS No | NA |
| Mol.F. | C15H23N3O4S |
| Mol.Wt. | 341.43 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142392 |
| CAS No | NA |
| Mol.F. | C15H24N4O3S |
| Mol.Wt. | 340.44 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142393 |
| CAS No | NA |
| Mol.F. | C14H21N3O4S |
| Mol.Wt. | 327.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142394 |
| CAS No | NA |
| Mol.F. | C13H19N3O4S |
| Mol.Wt. | 313.4 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142395 |
| CAS No | NA |
| Mol.F. | C12H17N3O4S |
| Mol.Wt. | 299.35 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142396 |
| CAS No | NA |
| Mol.F. | C20H17ClF2N6O4 |
| Mol.Wt. | 478.84 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142397 |
| CAS No | NA |
| Mol.F. | C16H13ClN2O3 |
| Mol.Wt. | 316.74 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142398 |
| CAS No | NA |
| Mol.F. | C16H13ClN2O6S |
| Mol.Wt. | 396.8 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142399 |
| CAS No | NA |
| Mol.F. | C16H9ClN2O2 |
| Mol.Wt. | 296.7 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142400 |
| CAS No | NA |
| Mol.F. | C16H14N2O2 |
| Mol.Wt. | 266.3 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142401 |
| CAS No | NA |
| Mol.F. | C16H15ClN2O2 |
| Mol.Wt. | 302.76 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |